The Barakat Lab aims to improve health equity for youth with cancer and their families by designing, evaluating, and implementing developmentally appropriate and accessible assessments and interventions that target medical and psychosocial outcomes across the cancer treatment trajectory.
Rochelle Bagatell, MD, chaired the multidisciplinary panel that developed the NCCN guidelines, which will help to direct treatment of a highly heterogeneous disease.
The Mitochondria and Cancer Connections (MC2) Research program leverages knowledge from existing centers to establish a novel, cutting-edge research initiative and enable the development of mechanistic understanding and novel therapeutic opportunities at the intersection of mitochondrial disease and pediatric cancer.
